Skip to main content

Perfusion; Complications

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Medtronic
MedtronicNJ - Phillipsburg
1 program
Perfusion Index ParameterN/A1 trial
Active Trials
NCT06586918Completed32Est. Sep 2024
Nihon Kohden
Nihon KohdenNEW YORK, NY
1 program
capillary refill indexN/A1 trial
Active Trials
NCT04144166Completed60Est. Dec 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MedtronicPerfusion Index Parameter
Nihon Kohdencapillary refill index

Clinical Trials (2)

Total enrollment: 92 patients across 2 trials

NCT06586918MedtronicPerfusion Index Parameter

Perfusion Index Parameter

Start: Sep 2024Est. completion: Sep 202432 patients
N/ACompleted
NCT04144166Nihon Kohdencapillary refill index

Evaluation of Capillary Refill Index

Start: Oct 2019Est. completion: Dec 201960 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.